Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Oct-23 6:13 PM View:  | Shannon James Samuel Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 23,638 | $116.50 | $2,753,830.00 | (100%) 23.64K to 0 | |
| 06-Oct-23 6:24 PM View: | Watkins Thomas Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 65,953 | $116.50 | $7,683,520.00 | (100%) 65.95K to 0 | |
| 06-Oct-23 6:10 PM View: | Santini Gino Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 18,655 | $116.50 | $2,173,310.00 | (100%) 18.66K to 0 | |
| 06-Oct-23 5:48 PM View: | Sherman Jeffrey W EVP and Chief Medical Officer | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 2,655 | $116.50 | $309,308.00 | (1%) 234.76K to 232.1K | |
| 06-Oct-23 6:17 PM View: | Daniel William F Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 31,915 | $116.50 | $3,718,100.00 | (40%) 79.58K to 47.67K | |
| 06-Oct-23 6:01 PM View: | Thompson Elizabeth H.Z. EVP, Research & Development | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 14,575 | $116.50 | $1,697,990.00 | (100%) 14.57K to 0 | |
| 06-Oct-23 6:22 PM View: | Mahony Susan Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 9,345 | $116.50 | $1,088,690.00 | (50%) 18.65K to 9.31K | |
| 06-Oct-23 5:54 PM View: | Desjardin Michael A. EVP, Technical Operations | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 126,838 | $116.50 | $14,776,600.00 | (100%) 126.84K to 0 | |
| 06-Oct-23 6:15 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 44,546 | $116.50 | $5,189,610.00 | (50%) 89.03K to 44.48K | |
| 06-Oct-23 6:21 PM View: | Witz Pascale Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 25,672 | $116.50 | $2,990,790.00 | (56%) 45.95K to 20.28K | |
| 06-Oct-23 6:19 PM View: | Grey Michael G Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 39,361 | $116.50 | $4,585,560.00 | (40%) 97.39K to 58.03K | |
| 06-Oct-23 6:03 PM View: | Pasternak Andy EVP, Chief Strategy Officer | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 56,338 | $116.50 | $6,563,380.00 | (100%) 56.34K to 0 | |
| 06-Oct-23 5:48 PM View: | Sherman Jeffrey W EVP and Chief Medical Officer | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 232,104 | $116.50 | $27,040,100.00 | (100%) 232.1K to 0 | |
| 06-Oct-23 6:17 PM View: | Daniel William F Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 47,670 | $116.50 | $5,553,560.00 | (100%) 47.67K to 0 | |
| 06-Oct-23 5:51 PM View: | Clayton Sean M. EVP, General Counsel | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 7,655 | $116.50 | $891,808.00 | (91%) 8.4K to 0.74K | |
| 06-Oct-23 5:57 PM View: | Walbert Timothy P Chairman, President and CEO Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 616,772 | $116.50 | $71,853,904.00 | (71%) 874.75K to 257.97K | |
| 06-Oct-23 6:22 PM View: | Mahony Susan Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 9,306 | $116.50 | $1,084,150.00 | (100%) 9.31K to 0 | |
| 06-Oct-23 6:13 PM View: | Shannon James Samuel Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 33,156 | $116.50 | $3,862,670.00 | (58%) 56.79K to 23.64K | |
| 06-Oct-23 6:24 PM View: | Watkins Thomas Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 110,447 | $116.50 | $12,867,100.00 | (63%) 176.4K to 65.95K | |
| 06-Oct-23 6:10 PM View: | Santini Gino Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 100,959 | $116.50 | $11,761,700.00 | (84%) 119.61K to 18.66K | |
| 06-Oct-23 6:15 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 44,482 | $116.50 | $5,182,150.00 | (100%) 44.48K to 0 | |
| 06-Oct-23 6:21 PM View: | Witz Pascale Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 20,279 | $116.50 | $2,362,500.00 | (100%) 20.28K to 0 | |
| 06-Oct-23 6:19 PM View: | Grey Michael G Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 58,031 | $116.50 | $6,760,610.00 | (100%) 58.03K to 0 | |
| 06-Oct-23 5:51 PM View: | Clayton Sean M. EVP, General Counsel | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 745 | $116.50 | $86,792.50 | (100%) 0.74K to 0 | |
| 06-Oct-23 5:57 PM View: | Walbert Timothy P Chairman, President and CEO Director | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 257,974 | $116.50 | $30,054,000.00 | (100%) 257.97K to 0 | |
| 06-Oct-23 5:59 PM View: | Cox Aaron EVP, Chief Financial Officer | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 556 | $116.50 | $64,774.00 | (100%) 0.56K to 0 | |
| 06-Oct-23 6:08 PM View: | McIlvenny Patrick Chief Accounting Officer | Horizon Pharma, Inc. (HZNP) | 06-Oct-23 | Disposition | 6,874 | $116.50 | $800,821.00 | (100%) 6.87K to 0 | |
| 02-Oct-23 10:00 PM View: | Shannon James Samuel Director | Horizon Pharma, Inc. (HZNP) | 29-Sep-23 | Option Exercise | 11,850 | $12.19 | $144,452.00 | 26% 44.94K to 56.79K | |
| 02-Oct-23 10:00 PM View: | Watkins Thomas Director | Horizon Pharma, Inc. (HZNP) | 29-Sep-23 | Option Exercise | 81,323 | $13.61 | $1,106,550.00 | 86% 95.08K to 176.4K | |
| 28-Sep-23 4:39 PM View: | Grey Michael G Director | Horizon Pharma, Inc. (HZNP) | 28-Sep-23 | Option Exercise | 20,000 | $15.96 | $319,200.00 | 26% 77.39K to 97.39K | |
| 27-Sep-23 5:13 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 26-Sep-23 | Option Exercise | 32,161 | $13.87 | $446,073.00 | 57% 56.87K to 89.03K | |
| 25-Sep-23 7:07 PM View: | Santini Gino Director | Horizon Pharma, Inc. (HZNP) | 22-Sep-23 | Option Exercise | 20,000 | $15.96 | $319,200.00 | 26% 76.52K to 96.52K | |
| 07-Sep-23 4:15 PM View: | Sherman Jeffrey W EVP and Chief Medical Officer | Horizon Pharma, Inc. (HZNP) | 06-Sep-23 | Gift | 2,165 | -- | -- | (< 1%) 236.92K to 234.76K | |
| 11-May-23 4:48 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 09-May-23 | Gift | 7,873 | -- | -- | 14% 56.87K to 64.74K | |
| 11-May-23 4:48 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 09-May-23 | Gift | 7,873 | -- | -- | (12%) 64.74K to 56.87K | |
| 02-May-23 10:00 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Payment of Exercise | 1,879 | $111.16 | $208,870.00 | (3%) 58.75K to 56.87K | |
| 02-May-23 10:00 PM View: | Witz Pascale Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Payment of Exercise | 1,879 | $111.16 | $208,870.00 | (4%) 47.83K to 45.95K | |
| 02-May-23 10:00 PM View: | Grey Michael G Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 5% 73.48K to 77.39K | |
| 02-May-23 10:00 PM View: | Himawan Jeff Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 7% 54.83K to 58.75K | |
| 02-May-23 10:00 PM View: | Daniel William F Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 5% 77.55K to 81.46K | |
| 02-May-23 10:00 PM View: | Mahony Susan Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 24% 16.62K to 20.53K | |
| 02-May-23 10:00 PM View: | Shannon James Samuel Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Payment of Exercise | 1,879 | $111.16 | $208,870.00 | (4%) 46.82K to 44.94K | |
| 02-May-23 10:00 PM View: | Watkins Thomas Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 4% 91.16K to 95.08K | |
| 02-May-23 10:00 PM View: | Santini Gino Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 5% 72.61K to 76.52K | |
| 02-May-23 10:00 PM View: | Witz Pascale Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 9% 43.92K to 47.83K | |
| 02-May-23 10:00 PM View: | Shannon James Samuel Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Option Exercise | 3,913 | -- | -- | 9% 42.91K to 46.82K | |
| 02-May-23 10:00 PM View: | Daniel William F Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Payment of Exercise | 1,879 | $111.16 | $208,870.00 | (2%) 81.46K to 79.58K | |
| 02-May-23 10:00 PM View: | Mahony Susan Director | Horizon Pharma, Inc. (HZNP) | 28-Apr-23 | Payment of Exercise | 1,879 | $111.16 | $208,870.00 | (9%) 20.53K to 18.65K | |
| 14-Mar-23 4:45 PM View: | Thompson Elizabeth H.Z. EVP, Research & Development | Horizon Pharma, Inc. (HZNP) | 13-Mar-23 | Gift | 2,000 | -- | -- | (12%) 16.57K to 14.57K | |
| 06-Mar-23 4:48 PM View: | Desjardin Michael A. EVP, Technical Operations | Horizon Pharma, Inc. (HZNP) | 02-Mar-23 | Option Exercise | 4,372 | $15.31 | $66,953.10 | 4% 122.19K to 126.56K |
